Insidermedicine Daily News (Video)
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured ...
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured by Google News and The News Room. April 25, 2007 Patients with HIV who are treated with protease inhibitors have an increased risk of heart attack, according to a study published in the New England Journal of Medicine. Combination antiretroviral therapy has had a dramatic effect in reducing illness and death associated with the HIV virus, however an earlier study showed that the risk of heart attacks increased by 17% with every year a patient spent on antiretroviral. It isn’t known, though, whether all antiretroviral drugs carry this risk. The assessment of the role of any specific drug is difficult because patients with HIV usually receive a combination of drugs, and often switch regimens because of the availability of newer substances, adverse events, or drug regimen failure. Previous studies have shown a relationship between the use of protease inhibitors, a class of antiretroviral drug, and cardiovascular disease, but there is little information on the risks associated with another class of antiretroviral therapy called nonnucleoside reverse-transcriptase inhibitors. In this study, more than 23,000 patients infected with the HIV virus were assessed to determine the incidence of heart attack and the association between heart attack and exposure to protease inhibitors or nonnucleoside reverse-transcriptase inhibitors. Confirming the earlier results, the researchers found the risk of having a heart attack increased by 16% per year of exposure to protease inhibitors alone, which is equal to twice the risk over five years. Not such effect was observed with nonnucleoside reverse-transcriptase inhibitors. It is thought that protease inhibitors raise the level of blood lipid, thereby increasing the risk of cardiovascular disease and heart attack. Patients treated with protease inhibitors should have their cholesterol and blood pressure levels monitored, and take steps to reduce their lifestyle-related risk factors. This includes maintaining a healthy weight, eating a low-fat diet rich in fruits in vegetables, and getting regular exercise. Reporting for Insidermedicine, I'm Dr. Susan Sharma.
Show all Visit Show Website http://www.insidermedicine.caRecently Aired
-
HD
Researchers use everyday eye movements to help diagnose Parkinson's, ADHD and FASD
(August 30, 2012 - Insidermedicine) From California - Everyday eye ...
(August 30, 2012 - Insidermedicine) From California - Everyday eye movements can be used to help detect neurological conditions, according to a report published in the Journal of Neurology. Researchers recorded eye movements in 100 participants who were instructed to simply watch television for 20 minutes. By comparing their results to normative eye-tracking data, researchers were able to identify participants with Parkinson's disease with 90% accuracy, as well as ADHD or fetal alcohol spectrum disorder (FASD) with 77% accuracy.
-
HD
Two breast cancer drugs linked to heart failure
(August 30, 2012 - Insidermedicine) From Seattle - A new ...
(August 30, 2012 - Insidermedicine) From Seattle - A new report published in the Journal of the National Cancer Institute finds two breast cancer chemotherapy drugs that raise risk of heart problems. Studying over 12,000 women with breast cancer, researchers found that treatment with anthracycline and/or trastuzumab raised risk of heart failure.
-
HD
Older adults who don't smoke and remain physically active can add several years to their life
(August 30, 2012 - Insidermedicine) From Sweden - Older adults ...
(August 30, 2012 - Insidermedicine) From Sweden - Older adults who have a healthy lifestyle can add several years to their life, according to a report published in the British Medical Journal. Researchers followed nearly 2,000 elderly individuals for 18 years, and found that a healthy lifestyle prolonged the women's lives by 5 years and the men's lives by 6
-
HD
Healthy living can add 6 years to lifespan; Two breast cancer chemotherapy drugs linked to heart problems; Eye movements help diagnose neurological conditions
(August 30, 2012 - Insidermedicine) From Sweden - Older adults ...
(August 30, 2012 - Insidermedicine) From Sweden - Older adults who have a healthy lifestyle can add several years to their life, according to a report published in the British Medical Journal. Researchers followed nearly 2,000 elderly individuals for 18 years, and found that a healthy lifestyle prolonged the women's lives by 5 years and the men's lives by 6. From Seattle - A new report published in the Journal of the National Cancer Institute finds two breast cancer chemotherapy drugs that raise risk of heart problems. Studying over 12,000 women with breast cancer, researchers found that treatment with anthracycline and/or trastuzumab raised risk of heart failure. From California - Everyday eye movements can be used to help detect neurological conditions, according to a report published in the Journal of Neurology. Researchers recorded eye movements in 100 participants who were instructed to simply watch television for 20 minutes. By comparing their results to normative eye-tracking data, researchers were able to identify participants with Parkinson's disease with 90% accuracy, as well as ADHD or fetal alcohol spectrum disorder (FASD) with 77% accuracy.
-
HD
Prostate cancer patients have longer lives if they take aspirin
(August 29, 2012 - Insidermedicine) From Texas - Research published ...
(August 29, 2012 - Insidermedicine) From Texas - Research published in the Journal of Clinical Oncology finds that aspirin may prolong life in prostate cancer patients. Studying nearly 6,000 men with prostate cancer, researchers found that 10-year mortality was significantly lower in those taking aspirin
-
HD
Smokers much more likely to suffer burst aneurysm
(August 29, 2012 - Insidermedicine) From South Korea - Smokers ...
(August 29, 2012 - Insidermedicine) From South Korea - Smokers are at significantly increased risk of suffering brain bleeds, according to a report published in the Journal of Neurology Neurosurgery and Psychiatry. Researchers compared over 400 cases of burst aneurysms to over 400 control cases, and found that smokers were at nearly 3x increased risk of brain bleeds.
-
HD
Regular moderate chocolate consumption lowers stroke risk in men
(August 29, 2012 - Insidermedicine) From Sweden - Chocolate may ...
(August 29, 2012 - Insidermedicine) From Sweden - Chocolate may help prevent strokes in men, according to a report published in Neurology. Researchers surveyed nearly 40,000 men ages 49-75 and followed them for 10 years. They found that those who regularly consumed moderate amounts of chocolate had a 17% lower risk of stroke.
-
HD
Chocolate lowers risk stroke in men; Smoking more than doubles risk of burst aneurysm; Aspirin may prolong life in prostate cancer patients
(August 28, 2012 - Insidermedicine) From Sweden - Chocolate may ...
(August 28, 2012 - Insidermedicine) From Sweden - Chocolate may help prevent strokes in men, according to a report published in Neurology. Researchers surveyed nearly 40,000 men ages 49-75 and followed them for 10 years. They found that those who regularly consumed moderate amounts of chocolate had a 17% lower risk of stroke. From South Korea - Smokers are at significantly increased risk of suffering brain bleeds, according to a report published in the Journal of Neurology Neurosurgery and Psychiatry. Researchers compared over 400 cases of burst aneurysms to over 400 control cases, and found that smokers were at nearly 3x increased risk of brain bleeds. From Texas - Research published in the Journal of Clinical Oncology finds that aspirin may prolong life in prostate cancer patients. Studying nearly 6,000 men with prostate cancer, researchers found that 10-year mortality was significantly lower in those taking aspirin
-
HD
Novel synthetic tuberculosis vaccines could save millions of lives
(August 28, 2012 - Insidermedicine) From India - Upgrading tuberculosis ...
(August 28, 2012 - Insidermedicine) From India - Upgrading tuberculosis vaccines can save millions of lives a year, according to a report published in Trends in Molecular Medicine. Nearly 2 million people die each year from Mycobacterium tuberculosis, a bacteria not adequately prevented by the current TB vaccine, BCG. Researchers propose that TB-endemic regions should be controlled with novel synthetic vaccines that are currently undergoing human clinical trials.
-
HD
FDA approves new drug, Stribild, for HIV; 10 year reduction in post-heart attack strokes; TB vaccines need to be improved
(August 28, 2012 - Insidermedicine) From Washington - The FDA ...
(August 28, 2012 - Insidermedicine) From Washington - The FDA has approved a new once-a-day pill for the treatment of HIV, known as Stribild. In clinical trials, between 88% and 90% of HIV patients had undetectable levels of the virus in their blood after 48 weeks of treatment with the drug. From Sweden - A new report presented at the European Society of Cardiology's annual congress finds a 10 year reduction in stroke rates following heart attack. Researchers reviewed data on nearly 200,000 Swedish heart attack patients, and found that patient's risk of stroke one year following the cardiovascular event dropped from 4.1% in 1998 to 2.1% in 2008. From India - Upgrading tuberculosis vaccines can save millions of lives a year, according to a report published in Trends in Molecular Medicine. Nearly 2 million people die each year from Mycobacterium tuberculosis, a bacteria not adequately prevented by the current TB vaccine, BCG. Researchers propose that TB-endemic regions should be controlled with novel synthetic vaccines that are currently undergoing human clinical trials.
